Philippines - English - FDA (Food And Drug Administration)

ambica international trading corp.; distributor: altomed pharmaceuticals, inc. - ketoanalogues , essential amino acids - film-coated tablet - 101 mg/86 mg/68 mg/67 mg/59 mg/105 mg/53 mg/38 mg/30 mg/23 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - 17751 - bone matrix implant, synthetic - actifuse shape is a synthetic hydroxapatite delivered in a a water-soluble alkylene oxide copolymer carrier. actifuse shape is available prepackaged in differnt volumes from 1.6ml to 15.8ml and can be applied directly to the defect site from the primary packaging. actifuse shape can also be dispensed into a sterile surgical bowl and mixed with sterile saline/water or autologus blood/bone marrow aspirate to decrease its viscosity to aid handling and then applied to the defect site. bone graft substitutes are intended to be used in place of cortico-cancellous or cancellous allograft or autograft bone. the mechanical environment for such uses experience either low load requirements or compression. typical surgical applications for bone graft substitutes are: small void filling, e.g. after removal of a small bone tumour or following bone fracture reduction or in osteotomies; spinal fusion, where a cage or screw fixation device is used to relieve the graft site from physiological loads. it is not intended to be used in place of cortical strut allograft bone where high tensile, torsion and/or bending strength are required. the products are used by orthopaedic surgeons in place of allograft bone (bone from humans stored in bone banks).

Australia - English - Department of Health (Therapeutic Goods Administration)

geistlich pharma australia pty ltd - 46426 - orthopaedic cartilage repair membrane - chondro gide is a bilayer collagen matrix used to cover articular cartilage defects treated with autologus chondrocyte transplantation or bone marrow stimulation techniques chondro-gide? is used to cover chondral or osteochondral defects treated with bone marrow stimulation techniques (e.g. amic? ? autologous matrix induced chondrogenesis). surgical approaches include arthrotomy or arthroscopy. the defects can be acute or chronic and be caused by a fall, accident or other traumatic events. defects are located at articular cartilage surfaces including hyaline cartilage in the knee, hip, and talus.

Australia - English - Department of Health (Therapeutic Goods Administration)

terumo bct australia pty ltd - 47153 - haematological concentrate system kit, bone marrow concentration - a collection of sterile devices typically used at the point of care for the rapid preparation of autologus bone marrow aspirate concentrate (bmac) from bone marrow aspirate. the kit components, with the bone marrow aspirate, are directly placed in the dedicated centrifuge that separates and concentrates the bone marrow. the cellular bmac preparations are typically applied to general and orthopedic surgical sites, or pre-mixed with graft material to assist the healing and/or graft acceptance process. the kit may include specimen drawing devices. this is a single use device